Home/Filings/4/0001235802-18-000127
4//SEC Filing

Asper Jason D. 4

Accession 0001235802-18-000127

CIK 0001492658other

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 4:24 PM ET

Size

5.2 KB

Accession

0001235802-18-000127

Insider Transaction Report

Form 4
Period: 2018-08-16
Asper Jason D.
Sr VP, Strategy & Corp. Dev.
Transactions
  • Sale

    Ordinary Shares, par value EUR 0.03 per share

    2018-08-16$27.18/sh775$21,06716,204 total
Footnotes (2)
  • [F1]These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units.
  • [F2]Includes 13,899 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan.

Issuer

Wright Medical Group N.V.

CIK 0001492658

Entity typeother

Related Parties

1
  • filerCIK 0001714435

Filing Metadata

Form type
4
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 4:24 PM ET
Size
5.2 KB